Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ
$9.99
$--
(0.00%)
Key Market Data
$636.36M | |
$9.99 | |
$10.01 | |
$9.86 | |
$9.99 | |
-- | |
0.00% | |
201K |
Drugs Made In America Acquisition II Corp. (DMII) Stock Price Today
Drugs Made In America Acquisition II Corp. (DMII) is currently trading at $9.99 as of null, reflecting a 0.00% move ($-0.00) from the previous close.
In the short term, the stock has returned +50.30% over the past four weeks. Over the last 12 months, Drugs Made In America Acquisition II Corp. has recorded a +1.11% price change, indicating a stable performance relative to the broader market.
Drugs Made In America Acquisition II Corp. (DMII) 7-Day Stock Price Changes
Over the past seven days, Drugs Made In America Acquisition II Corp. has traded within a short-term range shaped by market sentiment in the BLANK CHECKS sector. During this period, the stock moved from its previous closing price of $9.99 to the latest recorded price of $9.99, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (200,986), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, DMII has delivered a +50.30% return over the past month and a +1.11% change in the last 12 months, indicating a stable trend relative to its broader sector peers.
How to Buy Drugs Made In America Acquisition II Corp. (DMII)
You can buy and trade DMII on MEXC in three simple steps:
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for DMII and Execute Your Trade
Open the trading page, enter DMII in the search bar, select the amount of DMII you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.
What is Drugs Made In America Acquisition II Corp. (DMII)?
Drugs Made In America Acquisition II Corp is a blank check Company.
Drugs Made In America Acquisition II Corp. Information
| Industry | BLANK CHECKS |
| Employees | -- |
| Sector | BLANK CHECKS |
| Company Website |
Frequently Asked Questions (FAQ)
1.What is the current share price of Drugs Made In America Acquisition II Corp.?
The latest trading price for Drugs Made In America Acquisition II Corp. (Common Stock) is $ 9.99, compared with a previous closing price of $ 9.99. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for DMII can be tracked on the live chart and quote section on this page.
2.Is Drugs Made In America Acquisition II Corp. stock going up or down?
Looking at recent performances, DMII has returned +50.30% over the past month, +1.11% over the last six months and +1.11% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for Drugs Made In America Acquisition II Corp. stock, but keep in mind that past returns do not guarantee future results.
3.Where does DMII currently sit relative to its 52-week high and low?
In the most recent 52-week period, Drugs Made In America Acquisition II Corp. has traded between a low of $ 9.86 and a high of $ 10.01. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether DMII is currently nearer the top or the bottom of its one-year trading band.
4.How is Drugs Made In America Acquisition II Corp. classified by sector and industry?
Drugs Made In America Acquisition II Corp. is classified in the BLANK CHECKS sector. In practice, this means Drugs Made In America Acquisition II Corp. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing DMII’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BLANK CHECKS sector could influence Drugs Made In America Acquisition II Corp.’s performance.
5.Where is Drugs Made In America Acquisition II Corp. listed and how large is it by market value?
Drugs Made In America Acquisition II Corp. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 636.36M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Drugs Made In America Acquisition II Corp.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.
6.What does DMII's EPS tell investors about its profitability?
Trailing-twelve-month EPS of -- summarises how much profit Drugs Made In America Acquisition II Corp. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track Drugs Made In America Acquisition II Corp.'s financial performance over time?
To follow Drugs Made In America Acquisition II Corp.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how DMII is performing and how the market is responding.
8.When is Drugs Made In America Acquisition II Corp. expected to report earnings?
Drugs Made In America Acquisition II Corp.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for DMII, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in Drugs Made In America Acquisition II Corp.'s earnings reports?
Drugs Made In America Acquisition II Corp.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether DMII is meeting, beating or missing expectations.
10.How can I stay informed about Drugs Made In America Acquisition II Corp.'s results and guidance?
You can stay up to date on Drugs Made In America Acquisition II Corp. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for DMII on this page helps you see how new information is being reflected in the stock.
11.Does Drugs Made In America Acquisition II Corp. pay a regular cash dividend to its shareholders?
Drugs Made In America Acquisition II Corp. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor DMII's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for DMII?
Based on the latest earnings data, DMII has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Drugs Made In America Acquisition II Corp. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Drugs Made In America Acquisition II Corp. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is Drugs Made In America Acquisition II Corp.?
Drugs Made In America Acquisition II Corp. is a publicly traded company in the BLANK CHECKS industry within the BLANK CHECKS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is DMII valued in terms of P/E ratio and EPS?
Drugs Made In America Acquisition II Corp. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Drugs Made In America Acquisition II Corp.'s earnings. Comparing DMII's P/E and EPS to those of other BLANK CHECKS companies can help investors judge whether its valuation looks rich or attractive.
Explore More US Stocks
Stocks in the Same Sector
Browse other US stocks in the same sector as Drugs Made In America Acquisition II Corp.
Largest Market Cap
See US stocks with the highest market capitalization
Most Actively Traded
Discover today's most actively traded US stocks
Top Gainers
Browse today's leading gainers in the US stock market
Top 5 Cryptocurrencies
Explore the cryptocurrencies with the highest market capitalization
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
DMII-to-USD Calculator
Amount
1 DMII = 9.99 USD